Dynamic Technology Lab Private LTD Anavex Life Sciences Corp. Transaction History

Dynamic Technology Lab Private LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.55 - $9.37 $48,882 - $69,928	7,463 Added 56.86%	20,588 $135,000
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $112,418 - $139,422	-14,676 Reduced 52.79%	13,125 $107,000
Q1 2023 May 12, 2023	BUY	$8.32 - $11.75 $231,304 - $326,661	27,801 New	27,801 $238,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $305,017 - $553,980	-31,316 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$16.88 - $23.31 $528,614 - $729,975	31,316 New	31,316 $543,000

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $352M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.